ArticleBMC endocrine disorders2020

Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice.

Eliza B Geer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.